SCHEMBL20969720

SCHEMBL20969720

O=C(O)c1cccc2nc(Cl)sc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
PPARG P37231 1/20 0.42
NCOA2 Q15596 1/20 0.42
NCOA1 Q15788 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
DHODH Q02127 1/20 0.42
NR4A1 P22736 1/20 0.39
NR4A2 P43354 1/20 0.39
NR4A3 Q92570 1/20 0.39
NR1H4 Q96RI1 4/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL117199 0.81 ILK (0.53) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL17859467 0.81 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4EPPARGNCOA2
SCHEMBL5118299 0.81 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL8975728 0.79 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL687318 0.79 ALDH1A1 (0.46) ALDH1A1LMNAMEN1KMT2AGAA
SCHEMBL6112936 0.77 TSHR (0.50) ALDH1A1SMN1; SMN2TSHRMEN1KMT2A
SCHEMBL7556888 0.77 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2TSHRMEN1KMT2A
SCHEMBL5116616 0.77 SMN1; SMN2 (0.51) ALDH1A1SMN1; SMN2LMNAKDM4EDHODH
SCHEMBL9305900 0.76 APP (0.46) ALDH1A1SMN1; SMN2LMNATSHRKMT2A
SCHEMBL20859029 0.76 TLR8 (0.44) ALDH1A1SMN1; SMN2LMNATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3483149-B1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME YUHAN CORP (KR) 2021-01-13 EP disclosed
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same YUHAN CORPORATION (KR) 2019-08-20 US disclosed
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same YUHAN CORPORATION (KR) 2019-05-16 US disclosed
EP-3483149-A1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Yuhan Corporation (KR) 2019-05-15 EP disclosed
CN-107635984-A Heterocyclic substituted bicyclic azoles as pesticidal agents 杜邦公司 2018-01-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same ILK, SBDS, BDKRB1 ALDH1A1 3073/4885SMN1; SMN2 2540/4885LMNA 619/4885
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same ILK, SBDS, BDKRB1 ALDH1A1 3073/4885SMN1; SMN2 2540/4885LMNA 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.